JDOC Fact Sheet: JPMorgan Healthcare Leaders ETF
Share
$64.79
close, Nov 18, 2026
Over the year to Nov 18, 2026, JDOC returned +13.9% in total and charged 0.65% a year.
- 1-year total return
- +13.9%
- to Nov 18, 2026
- Expense ratio
- 0.65%
- a year
- Net assets
- $9.7m
- on Nov 18, 2026
- Net flow, last 3 trading days
- $0
- daily basis to Nov 16, 2026
Growth of $10,000, 1 year
JDOC $11,393 +13.9% · URTH $11,161 +11.6% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.
Returns
WindowTotal return
1 month+4.4%
3 months+0.4%
Year to date+12.0%
1 year+13.9%
3 years+38.0%
Total return, distributions reinvested, each window to Nov 18, 2026.
Ten largest positions
HoldingWeight
ELI LILLY AND COMPANY8.78%
ABBVIE INC COMMON STOCK8.47%
UNITEDHEALTH GROUP INC5.18%
JOHNSON & JOHNSON COMMON4.76%
NOVARTIS AG COMMON STOCK4.56%
THERMO FISHER SCIENTIFIC4.32%
ASTRAZENECA PLC COMMON4.11%
MERCK & CO INC COMMON3.49%
DANAHER CORP COMMON STOCK2.79%
INTUITIVE SURGICAL INC2.57%
JDOC top ten by weight, 49.0% of the fund, of its 53 equity positions, from the holdings published by its issuer for Nov 17, 2026.
Facts
Equity fund · Actively managed · First traded Nov 2, 2023 · Benchmark Its own holdings, as of Nov 17, 2026